Galectin Therapeutics has submitted a Fast Track application to the FDA to help expedite its clinical development program.
Melanie Sena
Advertisement
Melanie Sena is community editor of Pharmaceutical Technology.
Articles by Melanie Sena
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Trends and Challenges Impacting Highly Potent API Development
2
FAQ: Key Innovations in Drug Delivery and Formulation in 2025
3
Leap Forward in Automation Anticipated for Small-Molecule Drug Product Manufacturing
4
How Innovation and Risk Management Are Reshaping Modern Drug Manufacturing
5
